Safety of pembrolizumab while commencing treatment for hepatitis C with Harvoni (ledipasvir and sofosbuvir)

被引：3
|
作者：
Menon, Lalitha L. [1 ]
Chin, Beatrice [1 ]
Khattak, Muhammad A. [1 ,2 ,3 ]
机构：
[1] Fiona Stanley Hosp, Dept Oncol, Perth, WA, Australia
[2] Univ Western Australia, Dept Med Oncol, Perth, WA, Australia
[3] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2018年 / 48卷 / 12期
关键词：
D O I：
10.1111/imj.14131
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1542 / 1543
页数：2
相关论文
共 50 条
  • [1] A Combination of Ledipasvir and Sofosbuvir (Harvoni) for Hepatitis C
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1455): : 111 - 112
  • [2] Post Ledipasvir/sofosbuvir (Harvoni) Treatment: Is Hepatitis C Recurrence Around the Corner?
    Razjouyan, Hadie
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1357 - S1358
  • [3] Efficacy and Safety of Harvoni (Ledipasvir/Sofosbuvir) in HCV Treatment in a Community Setting
    Abdullah, Khalid
    Dawood, Hasan
    Ortiz, Herman
    Zela, Scott
    Egwim, Chukwuma
    Ankoma-Sey, Victor
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S564 - S565
  • [4] Safety analysis of sofosbuvir and ledipasvir for treating hepatitis C
    Fazel, Yousef
    Lam, Brian
    Golabi, Pegah
    Younossi, Zobair
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (08) : 1317 - 1326
  • [5] Sustained Viral Response after Treatment with Ledipasvir/Sofosbuvir (Harvoni®) in a Patient with Hepatitis C Following Intestine and Renal Transplantation
    Burnham, Alyssa
    Schiano, Thomas
    Moon, Jang
    Templeton, Angela
    Iyer, Kishore
    TRANSPLANTATION, 2017, 101 (06) : S108 - S108
  • [6] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E877 - E882
  • [7] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E877 - E882
  • [8] Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis C
    Cuenca-Lopez, Francisca
    Rivero, Antonio
    Rivero-Juarez, Antonio
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (01) : 105 - 112
  • [9] Treatment of Hepatitis C with Sofosbuvir/Ledipasvir in Elderly Veterans
    Blanquicett, C. J.
    Mirk, A.
    Cartwright, E.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2017, 65 : S100 - S100
  • [10] Safety and Efficacy of Ledipasvir and Sofosbuvir for Hepatitis C in a Community Setting
    Thukral, Chandrashekhar
    Vicari, Joseph J.
    Bernsten, Andrew
    Geissler, Kathy
    Popejoy, Sara
    GASTROENTEROLOGY, 2016, 150 (04) : S1105 - S1105
12345